2Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
3Musso G, Gambino R, Cassader M, Pagano G. Meta- analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severiW. Ann Med 2011, 43:617-649.
4Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natu- ral history? Am J Gastroentero12003, 98:1915-1917.
5Adams LA, Sanderson S, Lindor KD, Angulo P. The histo- logical course of nonalcoholic fatty liver disease: a longitu- dinal study of 103 patients with sequential liver biopsies. J Hepato12005, 42:132-138.
6Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathologi- cal study. Am J Gastroentero12003, 98:2042-2047.
7Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steato- hepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
8Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Ctin Gastroenterol Hepato12004, 2:1048-1058.
9Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154-160.
10Davila JA, Morgan RO, Shaib Y, McGlynn KA, E1-Serag HB. Hepatitis C infection and the increasing incidence of hepato-cellular carcinoma: a population-based study. Gastroenterol- ogy 2004, 127:1372-1380.
